Loss of LPS is involved in the virulence and resistance to colistin of colistin-resistantAcinetobacter nosocomialismutants selectedin vitro

Transcriptomic analysis of colistin-susceptible and colistin-resistant isolates identifies genes associated with colistin resistance in Acinetobacter baumannii

(2015) Y.K. Park et al.   CLINICAL MICROBIOLOGY AND INFECTION

Activity of Host Antimicrobials against Multidrug-Resistant Acinetobacter baumannii Acquiring Colistin Resistance through Loss of Lipopolysaccharide

(2014) M. Garcia-Quintanilla et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Emergence of carbapenemase-producing Gram-negative bacteria in Saint Petersburg, Russia

(2014) Vladimir A. Ageevets et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Worldwide dissemination of acquired carbapenem-hydrolysing class D β-lactamases in Acinetobacter spp. other than Acinetobacter baumannii

(2014) Esther Zander et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria

(2014) Abiola O. Olaitan et al.   Frontiers in Microbiology

Colistin Resistance in a Clinical Acinetobacter baumannii Strain Appearing after Colistin Treatment: Effect on Virulence and Bacterial Fitness

(2013) Rafael López-Rojas et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Biological Cost of Different Mechanisms of Colistin Resistance and Their Impact on Virulence in Acinetobacter baumannii

(2013) Alejandro Beceiro et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis

(2013) Ya-Sung Yang et al.   BMC INFECTIOUS DISEASES

Emergence of NDM-producing non-baumannii Acinetobacter spp. isolated from China

(2013) R. Zhang et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

First Report of Carbapenem-Resistant Acinetobacter nosocomialis Isolates Harboring ISAba1-blaOXA-23 Genes in Latin America

(2013) A. B. Teixeira et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Risk factors for imipenem-nonsusceptible Acinetobacter nosocomialis bloodstream infection

(2013) Lei Huang et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Immunogenicity of highly conserved recombinant VacJ outer membrane lipoprotein of Pasteurella multocida

(2013) Sathish Bhadravati Shivachandra et al.   VACCINE

PA2800 Plays an Important Role in Both Antibiotic Susceptibility and Virulence in Pseudomonas aeruginosa

(2012) Lixin Shen et al.   CURRENT MICROBIOLOGY

The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace

(2012) Ignasi Roca et al.   Frontiers in Microbiology

ThepmrCABOperon Mediates Polymyxin Resistance inAcinetobacter baumanniiATCC 17978 and Clinical Isolates through Phosphoethanolamine Modification of Lipid A

(2011) Luis A. Arroyo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colistin-Resistant, Lipopolysaccharide-Deficient Acinetobacter baumannii Responds to Lipopolysaccharide Loss through Increased Expression of Genes Involved in the Synthesis and Transport of Lipoproteins, Phospholipids, and Poly-β-1,6-N-Acetylglucosamine

(2011) Rebekah Henry et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Phosphoethanolamine Modification of Lipid A in Colistin-Resistant Variants of Acinetobacter baumannii Mediated by the pmrAB Two-Component Regulatory System

(2011) Alejandro Beceiro et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Structure–function relationships of CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii

(2011) Manuella Catel-Ferreira et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes

(2011) Y.-C. Lee et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Acinetobacter baumannii Resistant to Colistin Alters Its Antibiotic Resistance Profile: A Case Report From Spain

(2011) Rafael López-Rojas et al.   JOURNAL OF INFECTIOUS DISEASES

Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production

(2010) J. H. Moffatt et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System

(2009) M. D. Adams et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Virulent Synergistic Effect between Enterococcus faecalis and Escherichia coli Assayed by Using the Caenorhabditis elegans Model

(2008) Jean-Philippe Lavigne et al.   PLoS One